The effect of neuromodulation in post-stroke aphasia treatment

The effect of neuromodulation in post-stroke aphasia treatment - The effect of neuromodulation in post-stroke aphasia treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000056592

Enrollment

Registered

2025-01-01

Start date

2025-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke aphasia

Interventions

1 session : 20min tDCS + speech and language therapy 1session per week 5session

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients between the ages of 18 and 90 2) Patients diagnosed with stroke (cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage, cerebral vascular malformation) 3) Patients with aphasia symptoms and stable for at least 6 months after the onset of symptoms 4) Patients with no cognitive decline (eligible patients who can understand the explanation) 5) Patients with stable stroke symptoms 6) Patients who agree to pay the cost of the SPECT.

Exclusion criteria

Exclusion criteria: 1) Patients with a history of epilepsy 2) Patients with a history of neuropsychiatric disorders 3) Patients with metal implants in the body (including pacemakers) 4) Patients with a history of serious arrhythmia or heart failure

Design outcomes

Primary

Measure	Time frame
SPECT, SLTA, Naming task, other speech and language test	—

Countries

Japan

Contacts

Public ContactKei Shimmyo

Saitama Medical Center, Saitama Medical University Department of Rehabilitation Medicine

kshimmyo@saitama-med.ac.jp049-228-3259

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026